Published in J Addict Med on November 05, 2013
The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients. Drug Alcohol Depend (2014) 0.80
A mixed methods study of HIV-related services in buprenorphine treatment. Subst Abuse Treat Prev Policy (2017) 0.75
Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med (2007) 5.68
Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med (2006) 3.64
Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry (2004) 3.26
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry (2011) 3.15
Brief intervention for hazardous and harmful drinkers in the emergency department. Ann Emerg Med (2008) 3.12
Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend (2007) 2.99
The time course and significance of cannabis withdrawal. J Abnorm Psychol (2003) 2.70
A brief intervention reduces hazardous and harmful drinking in emergency department patients. Ann Emerg Med (2012) 2.68
The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. Am J Obstet Gynecol (2008) 2.60
HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychol Rev (2005) 2.49
Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? Clin Infect Dis (2012) 2.45
Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med (2007) 2.38
Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med (2007) 2.38
Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. Clin Infect Dis (2014) 2.24
Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. J Consult Clin Psychol (2006) 2.15
Gender and non-medical use of prescription opioids: results from a national US survey. Addiction (2007) 2.15
An evidence-based guide to writing grant proposals for clinical research. Ann Intern Med (2005) 2.13
Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction (2005) 2.05
Behavior change following diagnosis with acute/early HIV infection-a move to serosorting with other HIV-infected individuals. The NIMH Multisite Acute HIV Infection Study: III. AIDS Behav (2009) 2.03
The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med (2005) 1.98
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr (2011) 1.97
Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat (2008) 1.89
A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. Am J Med (2013) 1.77
Treatment of heroin dependence with buprenorphine in primary care. Am J Drug Alcohol Abuse (2002) 1.76
Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. Drug Alcohol Depend (2006) 1.73
The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? Drug Alcohol Depend (2005) 1.72
Terminal decontamination of patient rooms using an automated mobile UV light unit. Infect Control Hosp Epidemiol (2011) 1.67
A trial of integrated buprenorphine/naloxone and HIV clinical care. Clin Infect Dis (2006) 1.62
Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients. J Acquir Immune Defic Syndr (2011) 1.52
Gambling: an addictive behavior with health and primary care implications. J Gen Intern Med (2002) 1.52
The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment. J Gen Intern Med (2010) 1.51
Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. J Clin Psychiatry (2015) 1.51
Delay discounting in current and former marijuana-dependent individuals. Exp Clin Psychopharmacol (2010) 1.48
Co-occurring psychosocial problems and HIV risk among women attending drinking venues in a South African township: a syndemic approach. Ann Behav Med (2013) 1.46
Integrating buprenorphine treatment into office-based practice: a qualitative study. J Gen Intern Med (2008) 1.45
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. Am J Addict (2008) 1.45
Federal plan for prescriber education on opioids misses opportunities. Ann Intern Med (2012) 1.45
Beliefs about fetal alcohol spectrum disorder among men and women at alcohol serving establishments in South Africa. Am J Drug Alcohol Abuse (2014) 1.45
Information-Motivation-Behavioral Skills (IMB) Model: testing direct and mediated treatment effects on condom use among women in low-income housing. Ann Behav Med (2006) 1.44
Electronic media-based health interventions promoting behavior change in youth: a systematic review. JAMA Pediatr (2013) 1.43
Women and opioid dependence treatment: office-based versus opioid treatment program-based care? Subst Abus (2007) 1.42
Factors affecting disclosure in South African HIV-positive pregnant women. AIDS Patient Care STDS (2008) 1.41
Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans. Med Care (2006) 1.41
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. J Subst Abuse Treat (2007) 1.38
Lack of understanding of acute HIV infection among newly-infected persons-implications for prevention and public health: The NIMH Multisite Acute HIV Infection Study: II. AIDS Behav (2009) 1.37
Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications. J Gen Intern Med (2011) 1.37
AIDS-related stigma, HIV testing, and transmission risk among patrons of informal drinking places in Cape Town, South Africa. Ann Behav Med (2012) 1.36
Increased hospital and emergency department utilization by individuals with recent criminal justice involvement: results of a national survey. J Gen Intern Med (2014) 1.35
Long-term correlates of childhood abuse among adults with severe mental illness: adult victimization, substance abuse, and HIV sexual risk behavior. AIDS Behav (2007) 1.35
Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug Alcohol Depend (2013) 1.33
Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients. J Clin Psychiatry (2009) 1.33
Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department. Acad Emerg Med (2005) 1.31
The next therapeutic challenge in HIV: polypharmacy. Drugs Aging (2013) 1.30
Narrative review: buprenorphine for opioid-dependent patients in office practice. Ann Intern Med (2008) 1.30
Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients. Drug Alcohol Depend (2008) 1.30
Emotional adjustment in survivors of sexual assault living with HIV-AIDS. J Trauma Stress (2002) 1.28
Emotional distress in nonmetropolitan persons living with HIV disease enrolled in a telephone-delivered, coping improvement group intervention. Health Psychol (2004) 1.28
Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. J Gen Intern Med (2007) 1.27
Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial. Ann Intern Med (2010) 1.27
Lessons learned about behavioral science and acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: V. AIDS Behav (2009) 1.26
"Because he has bought for her, he wants to sleep with her": alcohol as a currency for sexual exchange in South African drinking venues. Soc Sci Med (2012) 1.25
Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence. Clin Infect Dis (2005) 1.24
Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort. Drug Alcohol Depend (2010) 1.23
A research agenda for enhancing appropriate opioid prescribing in primary care. J Gen Intern Med (2013) 1.23
The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med (2006) 1.21
Methamphetamine use is associated with childhood sexual abuse and HIV sexual risk behaviors among patrons of alcohol-serving venues in Cape Town, South Africa. Drug Alcohol Depend (2012) 1.20
Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV. AIDS Behav (2009) 1.20
Initial strategies for integrating buprenorphine into HIV care settings in the United States. Clin Infect Dis (2006) 1.19
Pain and substance-related pain-reduction behaviors among opioid dependent individuals seeking methadone maintenance treatment. Am J Addict (2009) 1.19
Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: genetic linkage analysis and FISH studies. Genes Chromosomes Cancer (2004) 1.19
The impact of shame on health-related quality of life among HIV-positive adults with a history of childhood sexual abuse. AIDS Patient Care STDS (2010) 1.19
Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci (2008) 1.18
Provider satisfaction with office-based treatment of opioid dependence: a systematic review. Subst Abus (2005) 1.18
Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. J Acquir Immune Defic Syndr (2011) 1.17
Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness. Community Ment Health J (2006) 1.16
The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment. J Acquir Immune Defic Syndr (2011) 1.14
In their own voices: a qualitative study of women's risk for intimate partner violence and HIV in South Africa. Violence Against Women (2007) 1.13
The effects of federal parity on substance use disorder treatment. Am J Manag Care (2014) 1.13
The association between chronic pain and prescription drug abuse in Veterans. Pain Med (2009) 1.12
Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative. J Acquir Immune Defic Syndr (2011) 1.10
The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence. Am J Addict (2010) 1.10